Literature DB >> 25816761

Retroviral proteases and their roles in virion maturation.

Jan Konvalinka1, Hans-Georg Kräusslich2, Barbara Müller3.   

Abstract

Proteolytic processing of viral polyproteins is essential for retrovirus infectivity. Retroviral proteases (PR) become activated during or after assembly of the immature, non-infectious virion. They cleave viral polyproteins at specific sites, inducing major structural rearrangements termed maturation. Maturation converts retroviral enzymes into their functional form, transforms the immature shell into a metastable state primed for early replication events, and enhances viral entry competence. Not only cleavage at all PR recognition sites, but also an ordered sequence of cleavages is crucial. Proteolysis is tightly regulated, but the triggering mechanisms and kinetics and pathway of morphological transitions remain enigmatic. Here, we outline PR structures and substrate specificities focusing on HIV PR as a therapeutic target. We discuss design and clinical success of HIV PR inhibitors, as well as resistance development towards these drugs. Finally, we summarize data elucidating the role of proteolysis in maturation and highlight unsolved questions regarding retroviral maturation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Keywords:  Antiretroviral therapy; Aspartic protease; Gag; Human immunodeficiency virus; Maturation; Protease inhibitor; Resistance; Retrovirus; Virus structure

Mesh:

Substances:

Year:  2015        PMID: 25816761     DOI: 10.1016/j.virol.2015.03.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  60 in total

1.  Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice.

Authors:  Juan Fontana; Paul W Keller; Emiko Urano; Sherimay D Ablan; Alasdair C Steven; Eric O Freed
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

2.  Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line.

Authors:  Morgan E Meissner; Luiza M Mendonça; Wei Zhang; Louis M Mansky
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 3.  Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling.

Authors:  M Bernetti; A Cavalli; L Mollica
Journal:  Medchemcomm       Date:  2017-01-30       Impact factor: 3.597

4.  Resistance to Second-Generation HIV-1 Maturation Inhibitors.

Authors:  Emiko Urano; Uddhav Timilsina; Justin A Kaplan; Sherimay Ablan; Dibya Ghimire; Phuong Pham; Nishani Kuruppu; Rebecca Mandt; Stewart R Durell; Theodore J Nitz; David E Martin; Carl T Wild; Ritu Gaur; Eric O Freed
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.

Authors:  Angelica N Martins; Abdul A Waheed; Sherimay D Ablan; Wei Huang; Alicia Newton; Christos J Petropoulos; Rodrigo D M Brindeiro; Eric O Freed
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

6.  Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.

Authors:  Emiko Urano; Sherimay D Ablan; Rebecca Mandt; Gary T Pauly; Dina M Sigano; Joel P Schneider; David E Martin; Theodore J Nitz; Carl T Wild; Eric O Freed
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

Review 7.  Investigational protease inhibitors as antiretroviral therapies.

Authors:  Narasimha M Midde; Benjamin J Patters; Pss Rao; Theodore J Cory; Santosh Kumar
Journal:  Expert Opin Investig Drugs       Date:  2016-08-02       Impact factor: 6.206

8.  The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility.

Authors:  Susan M Watanabe; Viviana Simon; Natasha D Durham; Brittney R Kemp; Satoshi Machihara; Kimdar Sherefa Kemal; Binshan Shi; Brian Foley; Hongru Li; Benjamin K Chen; Barbara Weiser; Harold Burger; Kathryn Anastos; Chaoping Chen; Carol A Carter
Journal:  Retrovirology       Date:  2016-09-06       Impact factor: 4.602

9.  Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations.

Authors:  Daniel W Kneller; Johnson Agniswamy; Robert W Harrison; Irene T Weber
Journal:  FEBS J       Date:  2020-01-23       Impact factor: 5.542

Review 10.  HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.

Authors:  Paul Spearman
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.